Literature DB >> 16202318

[Purification and characterization of corresponding antigen recognized by monoclonal antibody 183B2 against ovarian carcinoma].

Hui-fang Guo1, Jie Feng, Hong Zhang, Yu Yao, Hong-yan Cheng.   

Abstract

OBJECTIVE: To purify MAb183B2 corresponding antigen of ovarian carcinomas and study its physical and chemical characteristics.
METHODS: The strongest positive samples reacted with MAb183B2 were screened from ovarian cancer ascites with indirect enzyme linked immunosorbent assay (ELISA). Then the antigen was purified from ascitic fluid by affinity chromatography with MAb183B2. Nature of the purified antigen was examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot and its reactivity was determined after treatment with NaIO4, trypsin, pronase, neuraminidase, deglycolipid mixture and heating. Two dimensional electrophoresis combined with western blot was then used to isolate and identify the antigen from ovarian cancer cell line SKOV3.
RESULTS: The reactivity of the antigen after treated by NaIO4, neuraminidase and deglycolipid mixture was still positive, while it was negative after treated by trypsin, pronase and heating. The antigen proved to be composed of two different subunits of 56,000 and 25,000 by SDS-PAGE, and MAb183B2 could blot the 56,000 band by western blot. The antigen from the SKOV3 cell line displayed microheterogeneity appearing as three spots over a pI range 5.3 approximately 5.8 at 56,000.
CONCLUSIONS: The epitope of 183B2-antigen is at its peptide core. The antigen belongs to the Ig super family and might be a new ovarian carcinoma associated antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202318

Source DB:  PubMed          Journal:  Zhonghua Fu Chan Ke Za Zhi        ISSN: 0529-567X


  2 in total

1.  Evaluation of COC183B2 antibody targeting ovarian cancer by near-infrared fluorescence imaging.

Authors:  Chen Zhang; Xinyu Ling; Yanxiu Guo; Cunzhong Yuan; Hongyan Cheng; Xue Ye; Ruiqiong Ma; Yinli Zhang; Yi Li; Xiaohong Chang; Beihua Kong; Tao Liu; Heng Cui
Journal:  Chin J Cancer Res       Date:  2019-08       Impact factor: 5.087

2.  Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.

Authors:  Junchen Chen; Chen Zhang; Yanxiu Guo; Xiaohong Chang; Ruiqiong Ma; Xue Ye; Hongyan Cheng; Yi Li; Heng Cui
Journal:  World J Surg Oncol       Date:  2020-04-06       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.